U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895486) titled 'Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation' on March 19.
Brief Summary: The purpose of this study is to evaluate the safety and tolerability of co-administration of nOPV1 + nOPV2 in infants, relative to those receiving monovalent nOPV vaccines alone and whether two and/or three doses of co-administered nOPV1 and nOPV2 are non-inferior to corresponding doses of nOPV1 alone and nOPV2 alone.
Study Start Date: Sept. 29, 2025
Study Type: INTERVENTIONAL
Condition:
Poliomyelitis
Intervention:
BIOLOGICAL: Novel Oral Polio Vaccine Type 1 (nOPV1)
nOPV1 containing >10^7.0 CCID50 per dose
BIOLOG...